Urinary transforming growth factor β1 levels in hepatitis c virus- related chronic liver disease: Correlation between high levels and severity of disease

Hepatology

Volumn 25, Issue 5, 1997, Pages 1141-1146

  Tsai, Jung F A ^a   Jeng, Jen Eing ^a   Chuang, Lea Yea ^a   Chang, Wen Y U ^a   Tsai, Juei Hsiung ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; FEMALE; FIBROGENESIS; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; URINE LEVEL;

EID: 0030905768     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510250516     Document Type: Article

References (20)

1. Di Bisceglie AM, Hoofnagle JH. Chronic viral hepatitis. In: Zakim D, Boyer TD, eds. Hepatology: a textbook of liver disease. Ed 3. Philadelphia: Saunders, 1996:1229-1329.
2. Tsai JF, Jeng JE, Chang WY, Lin ZY, Tsai JH. Hepatitis C virus infection among patients with chronic liver disease in an area hyperendemic for hepatitis B. Scand J Gastroenterol 1994;29:550-552.
3. Tsai JF, Jeng JE, Chang WY, Ho MS, Lin ZY, Tsai JH. Independent and additive effect modification of hepatitis C and B viruses infection on the development of chronic hepatitis. J Hepatol 1996;24:271-276.
4. Tsai JF, Jeng JE, Chang WY, Ho MS, Lin ZY, Tsai JH. Circulating immune complexes in chronic hepatitis C. J Med Virol 1995;46:12-17.
5. Tsai JF, Jeng JE, Chang WY, Ho MS, Lin ZY, Tsai JH. Increased IgM-containing circulating immune complexes in patients co-infected with hepatitis C and hepatitis B. Medicine 1995;74:136-143.
6. Tsai JF, Jeng JE, Chang WY, Ho MS, Lin ZY, Tsai JH. Circulating immune complexes in chronic hepatitis related to hepatitis C and B viruses infection. Clin Immunol Immunopathol 1995;75:39-44.
7. Tsai JF, Chang WY, Jeng JE, Ho MS, Wang LY, Hsieh MY, Chern SC, et al. Hepatitis C virus infection as a risk factor for non-alcoholic liver cirrhosis in Taiwan. J Med Virol 1993;41:296-300.
8. Tsai JF, Chang WY, Jeng JE, Ho MS, Lin ZY, Tsai JH. Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study. Liver 1994;14:98-102.
9. Jeng JE, Tsai JF. Hepatitis C virus antibody in hepatocellular carcinoma in Taiwan. J Med Virol 1991;34:74-77.
10. Tsai JF, Jeng JE, Ho MS, Chang WY, Lin ZY, Tsai JH. Hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Chinese: a case-control study. Int J Cancer 1994;56:619-621.
11. Tsai JF, Chang WY, Jeng JE, Ho MS, Lin ZY, Tsai J. Effects of hepatitis C and B viruses infection on the development of hepatocellular carcinoma. J Med Virol 1994;44:92-95.
12. Tsai JF, Chang WY, Jeng JE, Ho MS, Lin ZY, Tsai JH. Frequency of raised α-fetoprotein level among Chinese patients with hepatocellular carcinoma related to hepatitis B and C. Br J Cancer 1994;69:1157-1159.
13. Tsai JF, Margolis HS, Jeng JE, Ho MS, Ko YC, Lin ZY, Chang WY, et al. Association between hepatitis B and C virus infection and Chinese hepatocellular carcinoma: a case-control study. In: Nishioka K, Suzuki H, Mishiro S, Oda T, eds. Viral hepatitis and liver disease. Tokyo: Springer-Verlag, 1994:697-700.
14. Tsai JF, Jeng JE, Ho MS, Chang WY, Hsiwh MY, Lin ZY, Tsai JH. Additive effect modification of hepatitis B surface antigen and e antigen on the development of hepatocellular carcinoma. Br J Cancer 1996;73:1498-1502.
15. Bissell DM, Maher JJ. Hepatic fibrosis and cirrhosis. In: Zakim D, Boyer TD, eds. Hepatology: a textbook of liver disease. Ed 3. Philadelphia: Saunders, 1996:506-525.
16. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. N Engl J Med 1994;331:1286-1292.
17. Malizia G, Brunt EM, Peters MG, Rizzo A, Broekelman TJ, McDonald JA. Growth factor and procollagen type I gene expression in human liver disease. Gastroenterology 1995;108:145-156.
18. Friedman SL. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 1993;328:1828-1835.
19. I and α in chronic liver disease: effects of interferon alpha therapy. N Engl J Med 1991;324:933-940.
20. Roberts AB, Sporn MB. The transforming growth factor betas. In: Sporn MB, Roberts AB, eds. Peptide growth factors and their receptors. Heidelberg, Germany: Springer-Verlag, 1990:419-472.